Hyper IgM Syndromes ANN DURANDY. B lymphocyte differentiation. T:B cell cooperation in germinal centres

Size: px
Start display at page:

Download "Hyper IgM Syndromes ANN DURANDY. B lymphocyte differentiation. T:B cell cooperation in germinal centres"

Transcription

1 lymphocyte differentiation Hyper Syndromes ANN DURANDY Hematopoietic stem cell Myeloid precursor Lymphoid precursor NK one marrow D19 mmature gd D19 Memory cell Th D27 D19 + gg ga Mature Plasma cell Secondary lymphoid organ T: cell cooperation in germinal centres D40L D40 TRMH SR L-R gg, ga, S µ δ S γ3 S ε S µ δ S γ3 S S ε S µ δ S γ3 S S ε Error prone S S ε : T follicular helper, TR: T cell receptor, MH : major histocompatibility complex class, D40L: D40 Ligand, L-R: interleukine receptor, SR: g class switch recombination, : Antibody maturation: class switch recombination and somatic hypermutation Sµ µ δ Sγ3 γ3 Sε ε Sµ µ δ Sγ3 γ3 S Sε ε Sµ µ δ Sγ3 γ3 S Sε ε γ3 Sγ3 excision circle δ Sµ Sε ε µ SµSε Sε 1. (SR) diverse antibodies gg, ga, gg: longer half-life, binding to Fcγ receptors, complement activation ga: mucosae localization : anti-parasite infection 2. () efficient antibodies Mutations in regions selection of cells expressing a R with high affinity for antigen (role of follicular dendritic cells) 1

2 g class switch recombination deficiencies g class switch recombination deficiencies Serum g levels: Serum g levels: gg ga gg ga Defective T/ cooperation (50%) ntrinsic cell defect (50%) Defective T/ cooperation (50%) ntrinsic cell defect (50%) T/ cooperation deficiencies g SR-deficiencies caused by impaired T/ cooperation: -D40L or AR D40-deficiency D40L D40 TRMH L-R SR gg, ga, -linked D40L-deficiency (most frequent of g-sr deficiencies) AR-D40-deficiency (very rare cause of g-sr deficiency) Susceptibility to bacterial infections from the first years of e Lack of germinal centres in secondary lymphoid organs ontrol D40L -/- : T follicular helper, TR: T cell receptor, MH : major histocompatibility complex class, D40L: D40 Ligand, L-R: interleukine receptor, SR: g class switch recombination, : Defective SR and Associated T cell defect in D40L or D40-deficiency D40L/D40 deficiencies combine a and a T cell defect D40L T D4 (+) D40 TRAg HLA L-R Dendritic cell nterleukine production pro-inflammatory: L1, L6, TNFa, anti-infectious: L12,L18, mpaired cell immunity: susceptibility to bacterial infections (100%) mpaired T cell immunity susceptibility to opportunistic infections (100%) Liver disease: sclerosing cholangitis (20%) Neutropenia (68%) Auto-immunity (5%) ancers (3%) Susceptibility to viral and opportunistic infections Pneumocystis Jirovici, Giardia Lamblia, ryptosporidium 2

3 -D40L or AR D40-deficiency: dinosis and treatment D40-induced NF-k activation defect g levels (Normal or increased, decreased gg and ga) Neutropenia Decrease number of D27+ memory cells Defective expression of D40L on activated T cells (-linked D40L def.) or of D40 on cells (AR D40 def.) ontrol ontrol D40L D40 TRMH NEMO NF-κ L-R SR gg, ga, D40L on activated TD4 cells D40 on cells Genetic analysis : mutations in D40L or D40 genes Treatment: g, A, bone-marrow transplantation NF-κ: nuclear factor κ, NEMO: NF-κ essential modulator, SR: g class switch recombination, : g SR-deficiency associated to anhydrotic ectodermal dysplasia -linked anhydrotic ectodermal dysplasia g class switch recombination deficiencies Serum g levels: ariable defect in SR and Defective response to polysaccharidic antigens Hypomorphic mutations in NEMO (NF-k essential modulator) gg ga Treatment: g, A, bone-marrow transplantation Defective T/ cooperation (50%) ntrinsic cell defect (50%) g SR-deficiencies caused by an intrinsic cell defect D40L D40 S µ δ S γ3 S ε S µ δ S γ3 S S ε TRMH L-R AD, UNG,.. SR gg, ga, S µ δ S γ3 S S ε Error prone S S ε AD: Activation-nduced cytidine Deaminase, UNG: Uracil-N glycosylase SR: g class switch recombination, : 3

4 Sγ3 δ µ γ3 excision circle SµSε Sµ µ δ Sγ3 γ3 Sε ε Sµ µ δ Sγ3 γ3 S Sε ε Sµ µ δ Sγ3 γ3 S Sε ε Sµ Sε ε Sε g SR-deficiency caused by defective in and S regions Error prone S µ δ S γ3 S ε S µ δ S γ3 S S ε AD UNG S µ δ S γ3 S S ε S S ε AD: Activation-nduced cytidine Deaminase, UNG: Uracil-N glycosylase Activation-nduced cytidine Deaminase deficiency g SR-deficiencies caused by defective Autosomal recessive inheritance (consanguinity: 10-62%) Susceptibility to bacterial infections: 100% Lymphadenopathies: 50-72% g levels (Normal or increased, complete lack of gg and ga) Lymphadenopathies Normal number of D27+ memory cells ontrol Genetic analysis: Activation induced cytidine deaminase (AD) 40% Uracil-N glycosylase(1%) Most are molecularly undefined: AD cofactor?(60%) Auto-immunity: 21% (AHA, TP, A hepatitis, RA, LED ) Defective SR and Treatment: g substitution g SR deficiencies caused by defective of S regions S µ δ S γ3 S ε AD UNG S µ δ S γ3 S S ε An g SR-deficiency associated to a defect Autosomal recessive inheritance Susceptibility to bacterial infections (100%) Lymphadenopathies (50%) Error prone S µ δ S γ3 S S ε S S ε Mab anti-ad labelling control patient Autoimmunity (AHA, TP, SLE, uveitis) (21%) E(-) lymphoproliferative disorder (11%), AML (4%) Defective SR, normal 4

5 g SR-deficiency associated to a defect: dinosis and treatment g SR-deficiencies g levels (Normal or increased, decreased gg and ga) Decrease number of D27+ cells Molecularly undefined cell defect AR-UNG? T and cell defect Differential dinosis: Ataxia Telangiectasia++ Treatment: g substitution, follow-up++ AD cofactor? -L D40L opportunistic infections auto-immunity AR-AD -L NEMO AR-D40 AD NSERM U768 Paris, France A. Fischer M. Forveille P. Gardès S. Kracker A. Léger F. Mazerolles Acknowledgements All the clinicians, patients and their families ευχαριστώ UNG 5

Antibody Structure. Antibodies

Antibody Structure. Antibodies Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against

More information

Antibody Structure supports Function

Antibody Structure supports Function Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against

More information

Immunogenetics. Immunodeficiency

Immunogenetics. Immunodeficiency 4.05.009 Immune response represents a system of recognition of foreign molecules. Immunogenetics Foreign molecules (proteins, glycoproteins, carbohydrates, ssdna, viruses) or parts of foreign molecules

More information

The generation of lymphocyte antigen receptors (Chapter 5):

The generation of lymphocyte antigen receptors (Chapter 5): The generation of lymphocyte antigen receptors (Chapter 5): 1. Ig Gene Rearrangement (somatic recombination). 2. Ig Somatic Hypermutation. 3. Ig Class Switching 4. T cell Receptor Gene Rearragement 1.

More information

4 Themes in B cell development + Ig class switch and somatic mutation Tony DeFranco, 10/28/13 Checkpoints in B cell development: feedback from Ig

4 Themes in B cell development + Ig class switch and somatic mutation Tony DeFranco, 10/28/13 Checkpoints in B cell development: feedback from Ig 4 Themes in B cell development + Ig class switch and somatic mutation Tony DeFranco, 10/28/13 Checkpoints in B cell development: feedback from Ig gene rearrangements Lineage commitment: transcription factors

More information

B cells Harry W Schroeder Jr MD PhD

B cells Harry W Schroeder Jr MD PhD B cells Harry W Schroeder Jr MD PhD Division of Clinical Immunology and Rheumatology Departments of Medicine, Microbiology, and Genetics University of Alabama at Birmingham Director, UAB Program in Immunology

More information

1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?

1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation? 1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please

More information

Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October

Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October APC Antigen processing (dendritic cells, MΦ et al.) Antigen "presentation" Ag/Ab complexes Antigenspecific triggering B T ANTIGEN Proliferation

More information

Cellular phenotyping and application of cytometry for diagnostics purposes Part I. dr n. med. Karolina Bukowska-Straková

Cellular phenotyping and application of cytometry for diagnostics purposes Part I. dr n. med. Karolina Bukowska-Straková Cellular phenotyping and application of cytometry for diagnostics purposes Part I dr n. med. Karolina Bukowska-Straková Flow cytometry - wikipedia definition ;-) Flow cytometry (abbreviated: FCM) is a

More information

Recombination Lecture, Dr. Aguilera 2/17/2014

Recombination Lecture, Dr. Aguilera 2/17/2014 Lymphocytes and Antigen Receptors Thymus T-Cells Lymph nodes Spleen } T+B-cells Paper Presentation: Bone Marrow Stem cells and B-cells Nat. Rev. Immunol. STEM CELL CLP Committed Lymphocyte Precursor T-cells

More information

Exam 3 4/25/07. Total of 7 questions, 100 points.

Exam 3 4/25/07. Total of 7 questions, 100 points. Exam 3 4/25/07 BISC 4A P. Sengupta Total of 7 questions, 100 points. QUESTION 1. Circle the correct answer. Total of 40 points 4 points each. 1. Which of the following is typically attacked by the antibody-mediated

More information

Adaptive Immunity: Specific Defenses of the Host

Adaptive Immunity: Specific Defenses of the Host PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R 17 Adaptive Immunity: Specific Defenses of the Host The Adaptive Immune System Adaptive immunity:

More information

Session 3 Lecture 1 Dynamics of the GIT Microbiome: Microbial Darwinism

Session 3 Lecture 1 Dynamics of the GIT Microbiome: Microbial Darwinism Session 3 Lecture 1 Dynamics of the GIT Microbiome: Microbial Darwinism 10 14 bacteria representing ~1000 species and many phyla live in a crowded ecological space: The GIT Four major phyla dominate: By

More information

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: LECTURE: 22 Title IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: Identify the chromosome that contains the gene segments that encode the surface immunoglobulin heavy chain

More information

Elevated Immunoglobulins and Paraproteins

Elevated Immunoglobulins and Paraproteins Elevated Immunoglobulins and Paraproteins NWL Pathology GP Study Afternoon Thursday 19 th October 2017 Dr Aristeidis Chaidos Consultant Haematologist and Honorary Senior Clinical Lecturer Hammersmith Hospital,

More information

MERIAL AVIAN SCIENCE REVIEW

MERIAL AVIAN SCIENCE REVIEW MERIAL AVIAN SCIENCE REVIEW THE BURSA OF FABRICIUS AND ITS ESSENTIAL ROLE IN B-CELL DEVELOPMENT AND ANTIBODY PRODUCTION. BY PROF. BERND KASPERS PROFESSOR OF ANIMAL PHYSIOLOGY UNIVERSITY OF MUNICH - GERMANY

More information

Immunoglobulins. Harper s biochemistry Chapter 49

Immunoglobulins. Harper s biochemistry Chapter 49 Immunoglobulins Harper s biochemistry Chapter 49 Immune system Detects and inactivates foreign molecules, viruses, bacteria and microorganisms Two components with 2 strategies B Lymphocytes (humoral immune

More information

Antibodies (Immunoglobulins)

Antibodies (Immunoglobulins) Antibodies (Immunoglobulins) The immune system plays a major role in the body s defense mechanisms against pathogens and other foreign bodies. It protects organisms from infection with a layered defense

More information

BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics

BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics I. B cell leukemia and lymphomas Immunophenotyping as part of the diagnostic work- up of hematologic malignancies offers a rapid and effective

More information

5/8/18. Function of antibodies. B-cell activation requires crosslinking of the BCR. Agenda

5/8/18. Function of antibodies. B-cell activation requires crosslinking of the BCR. Agenda Agenda Immunity Mediated by B cells and Antibodies Chapter 9 Parham Antibody production by B lymphocytes Surface immunoglobulin and co-receptor Activation by CD4 T cells IgM secretion plasma cells Hypermutation

More information

5/9/17. Function of antibodies. B-cell activation requires crosslinking. Agenda. Immunity Mediated by B cells and Antibodies Chapter 9 Parham

5/9/17. Function of antibodies. B-cell activation requires crosslinking. Agenda. Immunity Mediated by B cells and Antibodies Chapter 9 Parham Agenda Immunity Mediated by B cells and Antibodies Chapter 9 Parham Rob Roovers Antibody production by B lymphocytes Surface immunoglobulin and co-receptor Activation by CD4 T cells IgM secretion plasma

More information

Immunoglobulins Harry W Schroeder Jr MD PhD

Immunoglobulins Harry W Schroeder Jr MD PhD Immunoglobulins Harry W Schroeder Jr MD PhD Division of Developmental and Clinical Immunology Departments of Medicine, Microbiology, and Genetics University of Alabama at Birmingham Immunoglobulin Has

More information

Topic (7): Antibodies and Antigens

Topic (7): Antibodies and Antigens Topic (7): Antibodies and Antigens INTRODUCTION Antibodies (Abs) are one of the three classes of molecules able to differentiate between antigens [Ags] (the other two are T-cell receptor [TCR] and major

More information

Antibodies. Immunoglobulin (Ig) is a synonym for antibody. Most antibodies are found in the gamma globulin fraction of serum.

Antibodies. Immunoglobulin (Ig) is a synonym for antibody. Most antibodies are found in the gamma globulin fraction of serum. Antibodies Introduction Antibodies are a class of serum proteins which are induced following contact with antigen. They bind specifically with antigen which induced their formation. Immunoglobulin (Ig)

More information

D.K.M. COLLEGE FOR WOMEN (AUTONOMOUS), VELLORE-1 DEPARTMENT OF ZOOLOGY IMMUNOLOGY (15CZO6B)

D.K.M. COLLEGE FOR WOMEN (AUTONOMOUS), VELLORE-1 DEPARTMENT OF ZOOLOGY IMMUNOLOGY (15CZO6B) D.K.M. COLLEGE FOR WOMEN (AUTONOMOUS), VELLORE-1 DEPARTMENT OF ZOOLOGY IMMUNOLOGY (15CZO6B) SECTION-A (UNIT-I) 1. Lysozyme. 2. SALT(skin associated lymphoid tissues). 3. Innate immunity. 4. Sources of

More information

From regulation to reality challenges in translation of gene therapy and cell-based medicinal products

From regulation to reality challenges in translation of gene therapy and cell-based medicinal products From regulation to reality challenges in translation of gene therapy and cell-based medicinal products Gene therapy case study: ADA-SCID Alessandro Aiuti Jonathan Appleby HSR-TIGET is focused on the implementation

More information

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects

More information

Metodi e tecniche di ottimizzazione innovative per applicazioni elettromagnetiche

Metodi e tecniche di ottimizzazione innovative per applicazioni elettromagnetiche Metodi e tecniche di ottimizzazione innovative per applicazioni elettromagnetiche Algoritmi stocastici Parte 3 Artificial Immune Systems M. Repetto Dipartimento Ingegneria Elettrica Industriale - Politecnico

More information

In vitro cultures of bone marrow stromal cells and progenitor B cells can accurately recapitulate the normal steps of B cell development.

In vitro cultures of bone marrow stromal cells and progenitor B cells can accurately recapitulate the normal steps of B cell development. Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Dina, Tim, and I encourage all confused

More information

B cell development The stages of B cell development

B cell development The stages of B cell development Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Dina, Tim, and I encourage all confused

More information

GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY. Steven J. Norris, Ph.D

GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY. Steven J. Norris, Ph.D GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY Steven J. Norris, Ph.D Topics I. General principles II. The heavy chain Ig locus and VDJ rearrangement III. Light chain rearrangement. IV. Mechanisms of

More information

Novel cytokines in allergic disease

Novel cytokines in allergic disease Novel cytokines in allergic disease By Soohyun Kim, PhD KonKuk University, Seoul Korea Content Introduction (cytokine functions in immune responses) Discovery of Interleukin-32 IL-32 binding protein (a

More information

Antibody Structure, and the Generation of B-cell Diversity. Chapter 4 5/1/17

Antibody Structure, and the Generation of B-cell Diversity. Chapter 4 5/1/17 Antibody Structure, and the Generation of B-cell Diversity B cells recognize their antigen without needing an antigen presenting cell Chapter 4 Structure of Immunoglobulins Structure and function Immunoglobulin

More information

Immunology: Antibody Basics

Immunology: Antibody Basics e-learning JABSOM Immunology: Antibody Basics One :: General Structure Identify the Parts of an Antibody Two :: Isotypes Identify Antibody Isotypes Three :: Function Match Antibody Functions With Isotypes

More information

Overview of HLA Identical and Haploidentical BMT in SCID: Duke Experience

Overview of HLA Identical and Haploidentical BMT in SCID: Duke Experience Overview of HLA Identical and Haploidentical BMT in SCID: Duke Experience By: Rebecca H. Buckley, M.D. Duke University Medical Center Durham, NC 27710 Human Severe Combined Immunodeficiency (SCID) A fatal

More information

Humoral Immune Response. Dr. Iman Hussein Shehata Professor of Medical Microbiology and Immunology

Humoral Immune Response. Dr. Iman Hussein Shehata Professor of Medical Microbiology and Immunology Humoral Immune Response Dr. Iman Hussein Shehata Professor of Medical Microbiology and Immunology Intended Learning Outcomes By the end of this lesson the student is expected to: 1-Decribe the sequence

More information

Humoral Immunity. Humoral Immunity and Complement. B cell Antigens. Location of B Cell Activation. B Cell Activation T-dependent antigens

Humoral Immunity. Humoral Immunity and Complement. B cell Antigens. Location of B Cell Activation. B Cell Activation T-dependent antigens Humoral Immunity and Humoral Immunity Robert Beatty MCB150 Transfer of non-cell components of blood-- antibodies, complement Humoral immunity = antibody mediated B cell Antigens B Cell Activation of T-dependent

More information

Antibody Structure and Function

Antibody Structure and Function Antibody Structure and Function Keri C. Smith, Ph.D. January 22, 2008 (or) Anatomy and Physiology of Antibodies Overview Physical properties of antibodies Structural and molecular features Differences

More information

SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES

SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES ANTIBODY SPECIFICITY. This can be thought of in terms of the goodness of fit (affinity) between an antigenic determinant and a lymphocyte receptor or antibody.

More information

True Confessions: Ancillary Materials in a Cell Processing Lab. Cell Processing Section, DTM, CC, NIH David Stroncek, MD Chief, CPS, DTM, CC

True Confessions: Ancillary Materials in a Cell Processing Lab. Cell Processing Section, DTM, CC, NIH David Stroncek, MD Chief, CPS, DTM, CC True Confessions: Ancillary Materials in a Cell Processing Lab Cell Processing Section, DTM, CC, NIH David Stroncek, MD Chief, CPS, DTM, CC Mission Provide cellular and gene therapy products and services

More information

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003 Lecture 17: Drug targeting Last time: Today: Intracellular drug delivery Drug targeting Reading: T.J. Wickham, Ligand-directed targeting of genes to the site of disease, Nat. Med. 9(1) 135-139 (2003) Drug

More information

Flow Cytometry in the Diagnosis of Hematopoietic Neoplasia. Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle

Flow Cytometry in the Diagnosis of Hematopoietic Neoplasia. Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle Flow Cytometry in the Diagnosis of Hematopoietic Neoplasia Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle 1 Flow Cytometer 2 The Power of Flow Cytometry Single cell

More information

OpenStax-CNX module: m Antibodies * OpenStax. Abstract

OpenStax-CNX module: m Antibodies * OpenStax. Abstract OpenStax-CNX module: m44823 1 Antibodies * OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons Attribution License 3.0 By the end of this section, you will be able to:

More information

Targeted Gene Therapy in the Treatment of X-linked Hyper-IgM Syndrome. Caroline Kuo, MD Pediatric Allergy & Immunology Clinical Instructor

Targeted Gene Therapy in the Treatment of X-linked Hyper-IgM Syndrome. Caroline Kuo, MD Pediatric Allergy & Immunology Clinical Instructor Targeted Gene Therapy in the Treatment of X-linked Hyper-IgM Syndrome Caroline Kuo, MD Pediatric Allergy & Immunology Clinical Instructor 1 Disclosures None. Hyper-immunoglobulin M syndromes Heterogeneous

More information

Genetics and Genomics Chapter 4 Questions

Genetics and Genomics Chapter 4 Questions Genetics and Genomics Chapter 4 Questions Multiple Choice Questions Question 4.1 Which, if any, of the following statements is false? a) Most of the inherited changes in our DNA arise because of exposure

More information

Chapter 3. Clonal selection

Chapter 3. Clonal selection Chapter 3. Clonal selection I have called this principle, by which each slight variation, if useful, is preserved, by the term of Natural Selection -Charles Darwin, On the Origin of Species, 1859 4 The

More information

Course Agenda. Day One

Course Agenda. Day One Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an

More information

Introduction to Antibody Structure/Function. Med Chem 528

Introduction to Antibody Structure/Function. Med Chem 528 Introduction to Antibody Structure/Function Med Chem 528 Origins of antibodies Product of the adaptive immune system B cells (antibody based immunity) T cells (cell based immunity) Pre-exposure protects

More information

Therapeutic Proteins BIT 230

Therapeutic Proteins BIT 230 Therapeutic Proteins BIT 230 CLOTTING Haemophilia Benefix Blood Products ANTICOAGULANT THROMBOLYTIC AGENTS tissue plasminogen activator streptokinase Coagulation pathway Factor VIII (Haemophilia A) Factor

More information

Quantitative Determination Of Serum Iron, Unsaturated Iron Binding Capacity (UIBC), And Total Iron Binding Capacity (TIBC)

Quantitative Determination Of Serum Iron, Unsaturated Iron Binding Capacity (UIBC), And Total Iron Binding Capacity (TIBC) Quantitative Determination Of Serum Iron, Unsaturated Iron Binding Capacity (UIBC), And Total Iron Binding Capacity (TIBC) Objectives To Determine The Normal Level Of Serum Iron. To Determine The Use Of

More information

Fundamental properties of Stem Cells

Fundamental properties of Stem Cells Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell

More information

FELLOWSHIP PROGRAM IN CLINICAL IMMUNOLOGY

FELLOWSHIP PROGRAM IN CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM IN CLINICAL IMMUNOLOGY Department of Microbiology and Immunology Clinical Immunology Laboratory Rosalind Franklin University of Medicine and Science 1/20/17 Fellowship Program in Clinical

More information

Additional levels of regulation

Additional levels of regulation Transcription Regulation And Gene Expression in Eukaryotes Cycle G2 (lecture 13709) P. Matthias, May 26th, 2010 Additional levels of regulation Gene organization/localization Allelic exclusion AIRE: a

More information

Conditioning Murine B Cells for. Immunoglobulin A Production In vitro

Conditioning Murine B Cells for. Immunoglobulin A Production In vitro Conditioning Murine B Cells for Immunoglobulin A Production In vitro by Wilford Goh BSc Biomedical Science This thesis is presented for the Honours degree in Biomedical Science at Murdoch University School

More information

IMMU 7630 Fall 2018 ANTIBODY STRUCTURE

IMMU 7630 Fall 2018 ANTIBODY STRUCTURE IMMU 7630 Fall 2018 ANTIBODY STRUCTURE ANTIBODY IS IMMUNOGLOBULIN. Almost 130 years ago it was observed that a new activity appeared in the blood plasma of animals or humans who had been immunized with

More information

Genetic Control of Immune Responses

Genetic Control of Immune Responses Genetic Control of Immune Responses fatchiyah, lab of Molecular Biology Brawijaya University 1 3/26/2010 APC Antigen processing (M et al.) MHC-linked Antigen "presentation" Ag/Ab complexes ANTIGEN Antigenspecific

More information

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS A Prototype Ig Gene: Murine Kappa About 10 0 V κ gene segments 4 J Gene Segment s 1 C κ Gene Segmen t Multiple V gene segments, distant from J and C A few J gene segments One C gene segment GERMLINE Ig

More information

Bone Marrow Failure Research Program

Bone Marrow Failure Research Program Bone Marrow Failure Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and

More information

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire

More information

Blood Physiology. Blood Physiology. Dr. Rodolfo T. Rafael. Agglutination Hemolysis Immunology

Blood Physiology. Blood Physiology. Dr. Rodolfo T. Rafael. Agglutination Hemolysis Immunology Blood Physiology Dr. Rodolfo T. Rafael 1 Blood Physiology Agglutination Hemolysis Immunology 2 1 Agglutination is an antigen- antibody reaction Blood clumping of red blood cells Blood Typing 3 BLOOD TYPING

More information

Principles of HLA for clinicians

Principles of HLA for clinicians Principles of HLA for clinicians Professor Alejandro Madrigal Scientific Director Anthony Nolan Research Institute FIT FOR THE FUTURE ANRI Site Visit 2012 32,000 patients in search of a donor for stem

More information

TRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA

TRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA TRIANNI Media Kit CORPORATE HEADQUARTERS Trianni, Inc. San Francisco, CA Telephone: 1.866.374.9314 MEDIA CONTACT Mandy Boyd Director of Marketing @Trianni_mAb Website: Trianni.com TECHNOLOGY LEADERSHIP

More information

A Course on Meta-Heuristic Search Methods for Combinatorial Optimization Problems

A Course on Meta-Heuristic Search Methods for Combinatorial Optimization Problems A Course on Meta-Heuristic Search Methods for Combinatorial Optimization Problems AutOrI LAB, DIA, Roma Tre Email: mandal@dia.uniroma3.it January 20, 2014 Outline 1 2 3 4 Multi-parent crossover: http://citeseerx.ist.psu.edu/

More information

Interplay of Cells involved in Therapeutic Agent Immunogenicity. Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology

Interplay of Cells involved in Therapeutic Agent Immunogenicity. Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology Interplay of Cells involved in Therapeutic Agent Immunogenicity Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology Disclosure The author works with Amicus on an immunogenicity project

More information

Lecture 3. Used anti B cell marker antibodies to deplete in mice

Lecture 3. Used anti B cell marker antibodies to deplete in mice Lecture 3 V-Gene Rearrangement and Expression Used anti B cell marker antibodies to deplete in mice Rat anti mouse CD19, anti mouse B220, and anti mouse CD22. Mice were then injected with a secondary antibody

More information

Guideline on the clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg)

Guideline on the clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) 23 July 2015 EMA/CHMP/BPWP/410415/2011 rev 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular

More information

Antibodies (Recommended reading: Abbas et al., 4th edition, Chapter 3; Chapter 4; Janeway et al., 5th edition, Chapter 3)

Antibodies (Recommended reading: Abbas et al., 4th edition, Chapter 3; Chapter 4; Janeway et al., 5th edition, Chapter 3) HST 175 Antibodies (Recommended reading: Abbas et al., 4th edition, Chapter 3; Chapter 4; Janeway et al., 5th edition, Chapter 3) Antibodies protect us from a vast variety of pathogens. Indeed the antibody

More information

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies.

THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies. I. Introduction THE EUROPEAN BLOOD BANKING MARKET: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies Table of Contents II. Worldwide Technology and Market Overview

More information

HOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II

HOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II HOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II Monday, March 24, 2008 2:00 PM 4:00 PM Small Group Classrooms LEARNING GOAL Understanding in vitro assessment of immunologic

More information

Additional Practice Problems for Reading Period

Additional Practice Problems for Reading Period BS 50 Genetics and Genomics Reading Period Additional Practice Problems for Reading Period Question 1. In patients with a particular type of leukemia, their leukemic B lymphocytes display a translocation

More information

VCE Biology Units 3 and

VCE Biology Units 3 and VCE Biology Units 3 and 4 2015 The following is from the Biology Victorian Certificate of Education Study Design 2013 2016. Units 1 to 4: Key Skills Investigate and inquire scientifically formulate questions

More information

NGS-Based Clonality Testing Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD)

NGS-Based Clonality Testing Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD) NGS-Based Clonality Testing Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD) Maria Arcila, M.D. Memorial Sloan Kettering Cancer Center Educational Goals Review

More information

Chapter 5. Genetic Models. Organization and Expression of Immunoglobulin Genes 3. The two-gene model: Models to Explain Antibody Diversity

Chapter 5. Genetic Models. Organization and Expression of Immunoglobulin Genes 3. The two-gene model: Models to Explain Antibody Diversity Chapter 5 Organization and Expression of Immunoglobulin Genes 3 4 5 6 Genetic Models How to account for: ) Vast diversity of antibody specificities ) Presence of Variable regions at the amino end of Heavy

More information

Antibody-Mediated Immunity

Antibody-Mediated Immunity Color code: Important in red Extra in blue Antibody-Mediated Immunity For team error adjustments, click here Objectives To describe B-cells as the mediators of humoral immunity, (antibody-mediated immunity)

More information

MINIMIZE THE MAKESPAN FOR JOB SHOP SCHEDULING PROBLEM USING ARTIFICIAL IMMUNE SYSTEM APPROACH

MINIMIZE THE MAKESPAN FOR JOB SHOP SCHEDULING PROBLEM USING ARTIFICIAL IMMUNE SYSTEM APPROACH MINIMIZE THE MAKESPAN FOR JOB SHOP SCHEDULING PROBLEM USING ARTIFICIAL IMMUNE SYSTEM APPROACH AHMAD SHAHRIZAL MUHAMAD, 1 SAFAAI DERIS, 2 ZALMIYAH ZAKARIA 1 Professor, Faculty of Computing, Universiti Teknologi

More information

Title B-LYMPHOCYTE ACTIVATION AND ANTIBODY PRODUCTION

Title B-LYMPHOCYTE ACTIVATION AND ANTIBODY PRODUCTION LECTURE: 19 Title B-LYMPHOCYTE ACTIVATION AND ANTIBODY PRODUCTION LEARNING OBJECTIVES: The student should be able to: Enumerate the two different ways of B-cell activation. Explain the mechanism of naïve

More information

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p.

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p. Overview of Regulatory Expectations for Introducing Novel Therapies into Clinical Trials Introduction p. 1 Roles of Regulatory Scientists p. 2 Product Development and Availability p. 2 Data Requirements

More information

Artificial Immune Systems

Artificial Immune Systems Artificial Immune Systems Dr. Mario Pavone Department of Mathematics & Computer Science University of Catania mpavone@dmi.unict.it http://www.dmi.unict.it/mpavone/ Biological Immune System (1/4) Immunology

More information

Germline Gene Therapy

Germline Gene Therapy Germline Gene Therapy US275 Scientific Ethics John R. Hoffman Arcadia University 1 Germline gene therapy is the placement of new DNA into a fertilized egg. http://genmed.yolasite.com/basics-of-gene-therapy.php

More information

Exceptional Human Antibody Discovery. Corporate Overview

Exceptional Human Antibody Discovery. Corporate Overview Exceptional Human Antibody Discovery Corporate Overview Co 1 1 Our Mission Trianni is a biotech company with the scientific mission of creating optimized and highly versatile platforms for generation of

More information

Gene therapy. Findings by Alert

Gene therapy. Findings by Alert Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed

More information

Class XII - Biology Biotechnology and its Applications Chapter-wise Questions

Class XII - Biology Biotechnology and its Applications Chapter-wise Questions Class XII - Biology Biotechnology and its Applications Chapter-wise Questions MULTIPLE-CHOICE QUESTIONS 1. Bt cotton is not: a. A GM plant b. Insect resistant c. A bacterial gene expressing system d. Resistant

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pr e- B-ce ll B-ce ll Transformed B-ce ll Plasma cell Ig Su rf ace Su rf ace Secre ted Major malignant

More information

not to be republished NCERT BIOTECHNOLOGY AND ITS APPLICATIONS CHAPTER BIOLOGY, EXEMPLAR PROBLEMS MULTIPLE-CHOICE QUESTIONS

not to be republished NCERT BIOTECHNOLOGY AND ITS APPLICATIONS CHAPTER BIOLOGY, EXEMPLAR PROBLEMS MULTIPLE-CHOICE QUESTIONS 82 BIOLOGY, EXEMPLAR PROBLEMS CHAPTER 12 BIOTECHNOLOGY AND ITS APPLICATIONS 1. Bt cotton is not: a. A GM plant b. Insect resistant MULTIPLE-CHOICE QUESTIONS c. A bacterial gene expressing system d. Resistant

More information

ELISPOT and FLUOROSPOT kits

ELISPOT and FLUOROSPOT kits ELISPOT and FLUOROSPOT kits Interleukins Interferons Granzymes and perforins TNF superfamily ligands and receptors Apoptosis markers And many more... ELISPOT and FLUOROSPOT: a cell-based assay to assess

More information

Antibody Generation: challenges and solutions. Glen Marszalowicz, PHD May 10, AM

Antibody Generation: challenges and solutions. Glen Marszalowicz, PHD May 10, AM Antibody Generation: challenges and solutions Glen Marszalowicz, PHD May 10, 2015 9AM GenScript the most cited biology CRO CRISPR Services Gene Services Peptide Services Protein Services Antibody Services

More information

Genetics and Genomics in Medicine Chapter 9 Questions

Genetics and Genomics in Medicine Chapter 9 Questions Genetics and Genomics in Medicine Chapter 9 Questions Multiple Choice Questions Question 9.1 Which, if any, of the following can be classified as a type of augmentation therapy? a) Treatment using a small

More information

Copyright Nikita S. Kolhatkar

Copyright Nikita S. Kolhatkar Copyright 2015 Nikita S. Kolhatkar The Role of Altered Antigen Receptor Signaling in Selection and Homeostasis of Peripheral B cells in Wiskott-Aldrich Syndrome Nikita S. Kolhatkar A dissertation submitted

More information

Corporate Medical Policy Genetic Testing for Fanconi Anemia

Corporate Medical Policy Genetic Testing for Fanconi Anemia Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2017 3/2018 12/2017 Description

More information

Precigen Company Update

Precigen Company Update Precigen Company Update Helen Sabzevari, PhD President, Precigen 9 January 2019 JP Morgan 37 th Annual Healthcare Conference Forward-looking statements Precigen, Inc. is a subsidiary of Intrexon Corporation

More information

Stem Cells and Multiple Myeloma

Stem Cells and Multiple Myeloma Stem Cells and Multiple Myeloma What is Multiple Myeloma Multiple Myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow Plasma cells normally make proteins called

More information

Immunotherapy in myeloma

Immunotherapy in myeloma Immunotherapy in myeloma This Horizons Infosheet contains information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons Infosheet series provides information relating to

More information

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

FDA Update. Scott A. Brubaker, CTBS Director, Division of Human Tissues Office of Tissues and Advanced Therapies CBER/FDA

FDA Update. Scott A. Brubaker, CTBS Director, Division of Human Tissues Office of Tissues and Advanced Therapies CBER/FDA FDA Update Scott A. Brubaker, CTBS Director, Division of Human Tissues Office of Tissues and Advanced Therapies CBER/FDA 13 th Annual FDA and the Changing Paradigm for HCT/P Regulation February 13, 2017

More information

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal) STEM CELLS (p 2-8) Overview The body is made up of about 200 different kinds of specialised cells, such as muscle cells, nerve cells, fat cells and skin cells. Cells with the capacity to give rise to the

More information

Immunotherapy in myeloma

Immunotherapy in myeloma Immunotherapy in myeloma Horizons Infosheet Clinical trials and novel drugs This Horizons Infosheet provides information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons

More information

بسم اهلل الرمحن الرحيم

بسم اهلل الرمحن الرحيم بسم اهلل الرمحن الرحيم Definition Multiple myeloma is a neoplastic plasma cell dyscrasia (PCD) that generally produced a monoclonal immunoglobulin protein, characterized by a clinical pentad: (a) anemia;

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart

More information